<!-- Generated by pkgdown: do not edit by hand -->
<!DOCTYPE html>
<html>
  <head>
  <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1.0">

<title>Adverse Events by System Organ Class and Preferred Term — t_ae • tern</title>

<!-- jquery -->
<script src="https://code.jquery.com/jquery-3.1.0.min.js" integrity="sha384-nrOSfDHtoPMzJHjVTdCopGqIqeYETSXhZDFyniQ8ZHcVy08QesyHcnOUpMpqnmWq" crossorigin="anonymous"></script>
<!-- Bootstrap -->
<link href="https://maxcdn.bootstrapcdn.com/bootswatch/3.3.7/cerulean/bootstrap.min.css" rel="stylesheet" crossorigin="anonymous">

<script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.7/js/bootstrap.min.js" integrity="sha384-Tc5IQib027qvyjSMfHjOMaLkfuWVxZxUPnCJA7l2mCWNIpG9mGCD8wGNIcPD7Txa" crossorigin="anonymous"></script>

<!-- Font Awesome icons -->
<link href="https://maxcdn.bootstrapcdn.com/font-awesome/4.6.3/css/font-awesome.min.css" rel="stylesheet" integrity="sha384-T8Gy5hrqNKT+hzMclPo118YTQO6cYprQmhrYwIiQ/3axmI1hQomh7Ud2hPOy8SP1" crossorigin="anonymous">

<!-- clipboard.js -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/1.7.1/clipboard.min.js" integrity="sha384-cV+rhyOuRHc9Ub/91rihWcGmMmCXDeksTtCihMupQHSsi8GIIRDG0ThDc3HGQFJ3" crossorigin="anonymous"></script>

<!-- sticky kit -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/sticky-kit/1.1.3/sticky-kit.min.js" integrity="sha256-c4Rlo1ZozqTPE2RLuvbusY3+SU1pQaJC0TjuhygMipw=" crossorigin="anonymous"></script>

<!-- pkgdown -->
<link href="../pkgdown.css" rel="stylesheet">
<script src="../pkgdown.js"></script>



<meta property="og:title" content="Adverse Events by System Organ Class and Preferred Term — t_ae" />

<meta property="og:description" content="t_ae returns adverse events summary table that corresponds to STREAM template AET02" />
<meta name="twitter:card" content="summary" />

<meta name="robots" content="noindex">

<!-- mathjax -->
<script src='https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML'></script>

<!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]-->


  </head>

  <body>
    <div class="container template-reference-topic">
      <header>
      <div class="navbar navbar-default navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar">
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <span class="navbar-brand">
        <a class="navbar-link" href="../index.html">tern</a>
        <span class="label label-danger" data-toggle="tooltip" data-placement="bottom" title="In-development package">0.5.0.1</span>
      </span>
    </div>

    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav">
        <li>
  <a href="../index.html">
    <span class="fa fa-home fa-lg"></span>
     
  </a>
</li>
<li>
  <a href="../reference/index.html">Reference</a>
</li>
<li>
  <a href="../news/index.html">Changelog</a>
</li>
      </ul>
      
      <ul class="nav navbar-nav navbar-right">
        <li>
  <a href="https://github.roche.com/Rpackages/tern">
    <span class="fa fa-github"></span>
     
  </a>
</li>
      </ul>
      
    </div><!--/.nav-collapse -->
  </div><!--/.container -->
</div><!--/.navbar -->

      
      </header>

<div class="row">
  <div class="col-md-9 contents">
    <div class="page-header">
    <h1>Adverse Events by System Organ Class and Preferred Term</h1>
    
    <div class="hidden name"><code>t_ae.Rd</code></div>
    </div>

    <div class="ref-description">
    
    <p><code>t_ae</code> returns adverse events summary table that corresponds to STREAM template AET02</p>
    
    </div>

    <pre class="usage"><span class='fu'>t_ae</span>(<span class='no'>class</span>, <span class='no'>term</span>, <span class='no'>id</span>, <span class='no'>col_by</span>, <span class='no'>col_N</span>, <span class='kw'>total</span> <span class='kw'>=</span> <span class='st'>"All Patients"</span>)</pre>
    
    <h2 class="hasAnchor" id="arguments"><a class="anchor" href="#arguments"></a>Arguments</h2>
    <table class="ref-arguments">
    <colgroup><col class="name" /><col class="desc" /></colgroup>
    <tr>
      <th>class</th>
      <td><p>class information as character or factor vector</p></td>
    </tr>
    <tr>
      <th>term</th>
      <td><p>term information as character or factor vector, however factor
levels are not repeated by class, only terms with count &gt; 1 are listed per
class</p></td>
    </tr>
    <tr>
      <th>id</th>
      <td><p>unique subject identifier. If a particular subject has no adverse
event then that information needs to be added to the <code>col_N</code> argument.</p></td>
    </tr>
    <tr>
      <th>col_by</th>
      <td><p>group variable that will be used for a column header. <code>col_by</code>
has to be a factor and can not be missing. See 'Examples'.</p></td>
    </tr>
    <tr>
      <th>col_N</th>
      <td><p>numeric vector with information of the number of patients in the
levels of <code>col_by</code>. This is useful if there are patients that have no
adverse events can be accounted for with this argument.</p></td>
    </tr>
    <tr>
      <th>total</th>
      <td><p>character string that will be used as a label for a column with 
pooled total population, default is "All Patients". If the levels of col_by are 
the only columns of interest then total should be <code>NULL</code></p></td>
    </tr>
    </table>
    

    <h2 class="hasAnchor" id="examples"><a class="anchor" href="#examples"></a>Examples</h2>
    <pre class="examples"><div class='input'><span class='co'># Simple example</span>
<span class='fu'>library</span>(<span class='no'>tibble</span>)
<span class='fu'>library</span>(<span class='no'>dplyr</span>)

<span class='no'>ASL</span> <span class='kw'>&lt;-</span> <span class='fu'><a href='http://www.rdocumentation.org/packages/tibble/topics/tibble'>tibble</a></span>(
  <span class='kw'>USUBJID</span> <span class='kw'>=</span> <span class='fu'>paste0</span>(<span class='st'>"id-"</span>, <span class='fl'>1</span>:<span class='fl'>10</span>),
  <span class='kw'>ARM</span> <span class='kw'>=</span> <span class='fu'>factor</span>(<span class='fu'>paste</span>(<span class='st'>"ARM"</span>, <span class='no'>LETTERS</span>[<span class='fu'>rep</span>(<span class='fu'>c</span>(<span class='fl'>1</span>,<span class='fl'>2</span>), <span class='fu'>c</span>(<span class='fl'>3</span>,<span class='fl'>7</span>))]))
)


<span class='no'>ae_lookup</span> <span class='kw'>&lt;-</span> <span class='fu'><a href='http://www.rdocumentation.org/packages/tibble/topics/tribble'>tribble</a></span>(
  ~<span class='no'>CLASS</span>,         ~<span class='no'>TERM</span>,   ~<span class='no'>GRADE</span>,
  <span class='st'>"cl A"</span>,   <span class='st'>"trm A_1/2"</span>,        <span class='fl'>1</span>,
  <span class='st'>"cl A"</span>,   <span class='st'>"trm A_2/2"</span>,        <span class='fl'>2</span>,
  <span class='st'>"cl B"</span>,   <span class='st'>"trm B_1/3"</span>,        <span class='fl'>2</span>,
  <span class='st'>"cl B"</span>,   <span class='st'>"trm B_2/3"</span>,        <span class='fl'>3</span>,
  <span class='st'>"cl B"</span>,   <span class='st'>"trm B_3/3"</span>,        <span class='fl'>1</span>,
  <span class='st'>"cl C"</span>,   <span class='st'>"trm C_1/1"</span>,        <span class='fl'>1</span>
)

<span class='no'>AAE</span> <span class='kw'>&lt;-</span> <span class='fu'>cbind</span>(
  <span class='fu'><a href='http://www.rdocumentation.org/packages/tibble/topics/tibble'>tibble</a></span>(
    <span class='kw'>USUBJID</span> <span class='kw'>=</span> <span class='no'>ASL</span>$<span class='no'>USUBJID</span>[<span class='fu'>c</span>(<span class='fl'>2</span>,<span class='fl'>2</span>,<span class='fl'>2</span>,<span class='fl'>3</span>,<span class='fl'>3</span>,<span class='fl'>4</span>,<span class='fl'>4</span>,<span class='fl'>4</span>,<span class='fl'>4</span>,<span class='fl'>5</span>,<span class='fl'>6</span>,<span class='fl'>6</span>,<span class='fl'>7</span>,<span class='fl'>7</span>)]
  ),
  <span class='no'>ae_lookup</span>[<span class='fu'>c</span>(<span class='fl'>1</span>,<span class='fl'>1</span>,<span class='fl'>2</span>,<span class='fl'>6</span>,<span class='fl'>4</span>,<span class='fl'>2</span>,<span class='fl'>2</span>,<span class='fl'>3</span>,<span class='fl'>4</span>,<span class='fl'>2</span>,<span class='fl'>1</span>,<span class='fl'>5</span>,<span class='fl'>4</span>,<span class='fl'>6</span>),]
)

<span class='no'>ANL</span> <span class='kw'>&lt;-</span> <span class='fu'><a href='http://dplyr.tidyverse.org/reference/join.html'>left_join</a></span>(<span class='no'>AAE</span>, <span class='no'>ASL</span>, <span class='kw'>by</span> <span class='kw'>=</span> <span class='st'>"USUBJID"</span>)

<span class='no'>tbl</span> <span class='kw'>&lt;-</span> <span class='fu'>t_ae</span>(
  <span class='kw'>class</span> <span class='kw'>=</span> <span class='no'>ANL</span>$<span class='no'>CLASS</span>,
  <span class='kw'>term</span> <span class='kw'>=</span>  <span class='no'>ANL</span>$<span class='no'>TERM</span>,
  <span class='kw'>id</span> <span class='kw'>=</span> <span class='no'>ANL</span>$<span class='no'>USUBJID</span>,
  <span class='kw'>col_by</span> <span class='kw'>=</span> <span class='no'>ANL</span>$<span class='no'>ARM</span>,
  <span class='kw'>col_N</span> <span class='kw'>=</span> <span class='fu'>tapply</span>(<span class='no'>ASL</span>$<span class='no'>ARM</span>, <span class='no'>ASL</span>$<span class='no'>ARM</span>, <span class='no'>length</span>),
  <span class='kw'>total</span> <span class='kw'>=</span> <span class='st'>"All Patients"</span>
)

<span class='no'>tbl</span></div><div class='output co'>#&gt; MedDRA System Organ Class                                                    ARM A               ARM B            All Patients
#&gt;   MedDRA Preferred Term                                                      (N=3)               (N=7)               (N=10)   
#&gt; ------------------------------------------------------------------------------------------------------------------------------
#&gt; - Any Adverse Event -
#&gt;   Overall total number of events                                               5                   9                   14     
#&gt;   Overall total number of patients with at least one adverse event         2 (66.67%)          4 (57.14%)           6 (60%)   
#&gt; 
#&gt; cl A
#&gt;   Total number of events                                                       3                   4                   7      
#&gt;   Total number of patients with at least one adverse event                 1 (33.33%)          3 (42.86%)           4 (40%)   
#&gt;   trm A_2/2                                                                1 (33.33%)          2 (28.57%)           3 (30%)   
#&gt;   trm A_1/2                                                                1 (33.33%)          1 (14.29%)           2 (20%)   
#&gt; 
#&gt; cl B
#&gt;   Total number of events                                                       1                   4                   5      
#&gt;   Total number of patients with at least one adverse event                 1 (33.33%)          3 (42.86%)           4 (40%)   
#&gt;   trm B_2/3                                                                1 (33.33%)          2 (28.57%)           3 (30%)   
#&gt;   trm B_1/3                                                                 NA (NA%)           1 (14.29%)           1 (10%)   
#&gt;   trm B_3/3                                                                 NA (NA%)           1 (14.29%)           1 (10%)   
#&gt; 
#&gt; cl C
#&gt;   Total number of events                                                       1                   1                   2      
#&gt;   Total number of patients with at least one adverse event                 1 (33.33%)          1 (14.29%)           2 (20%)   
#&gt;   trm C_1/1                                                                1 (33.33%)          1 (14.29%)           2 (20%)   </div><div class='input'>

<span class='fu'>library</span>(<span class='no'>random.cdisc.data</span>)
<span class='fu'>library</span>(<span class='no'>dplyr</span>)

<span class='no'>ASL</span> <span class='kw'>&lt;-</span> <span class='fu'><a href='http://www.rdocumentation.org/packages/random.cdisc.data/topics/radam'>radam</a></span>(<span class='st'>"ASL"</span>, <span class='kw'>N</span> <span class='kw'>=</span> <span class='fl'>10</span>)
<span class='no'>AAE</span> <span class='kw'>&lt;-</span> <span class='fu'><a href='http://www.rdocumentation.org/packages/random.cdisc.data/topics/radam'>radam</a></span>(<span class='st'>"AAE"</span>, <span class='kw'>ADSL</span> <span class='kw'>=</span> <span class='no'>ASL</span>)

<span class='no'>ANL</span> <span class='kw'>&lt;-</span> <span class='fu'><a href='http://dplyr.tidyverse.org/reference/join.html'>left_join</a></span>(<span class='no'>AAE</span>, <span class='no'>ASL</span> <span class='kw'>%&gt;%</span> <span class='fu'><a href='http://dplyr.tidyverse.org/reference/select.html'>select</a></span>(<span class='no'>USUBJID</span>, <span class='no'>STUDYID</span>, <span class='no'>ARM</span>), <span class='kw'>by</span> <span class='kw'>=</span> <span class='fu'>c</span>(<span class='st'>"STUDYID"</span>, <span class='st'>"USUBJID"</span>))

<span class='no'>tbl</span> <span class='kw'>&lt;-</span> <span class='fu'>with</span>(<span class='no'>ANL</span>,
            <span class='fu'>t_ae</span>(
              <span class='kw'>class</span> <span class='kw'>=</span> <span class='no'>AEBODSYS</span>,
              <span class='kw'>term</span> <span class='kw'>=</span>  <span class='no'>AEDECOD</span>,
              <span class='kw'>id</span> <span class='kw'>=</span> <span class='no'>USUBJID</span>,
              <span class='kw'>col_by</span> <span class='kw'>=</span> <span class='fu'>factor</span>(<span class='no'>ARM</span>),
              <span class='kw'>total</span> <span class='kw'>=</span> <span class='st'>"All Patients"</span>
            )
)

<span class='no'>tbl</span></div><div class='output co'>#&gt; MedDRA System Organ Class                                                     ARM A               ARM B            All Patients
#&gt;   MedDRA Preferred Term                                                       (N=49)              (N=10)              (N=59)   
#&gt; -------------------------------------------------------------------------------------------------------------------------------
#&gt; - Any Adverse Event -
#&gt;   Overall total number of events                                                49                  10                  59     
#&gt;   Overall total number of patients with at least one adverse event          9 (18.37%)           1 (10%)           10 (16.95%) 
#&gt; 
#&gt; Investigations
#&gt;   Total number of events                                                        12                  3                   15     
#&gt;   Total number of patients with at least one adverse event                  5 (10.2%)            1 (10%)            6 (10.17%) 
#&gt;   Carbon dioxide combining power decreased                                  1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt;   Ehrlichia test                                                            1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt;   Prekallikrein test                                                        1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt;   Chest scan                                                                1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt;   Biopsy heart normal                                                       1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt;   Xanthochromia                                                             1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt;   Bile culture                                                              1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt;   Secretion gastric absent                                                  1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt;   Blood cholinesterase                                                      1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt;   Anti-glomerular basement membrane antibody                                1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt;   Metamyelocyte count                                                       1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt;   Physical thyroid examination                                               NA (NA%)            1 (10%)            1 (1.69%)  
#&gt;   CSF specific gravity                                                       NA (NA%)            1 (10%)            1 (1.69%)  
#&gt;   Fluoride increased                                                         NA (NA%)            1 (10%)            1 (1.69%)  
#&gt;   Blood bromide                                                             1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt; 
#&gt; Injury, poisoning and procedural complications
#&gt;   Total number of events                                                        3                   2                   5      
#&gt;   Total number of patients with at least one adverse event                  3 (6.12%)            1 (10%)            4 (6.78%)  
#&gt;   Graft ischaemia                                                           1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt;   Cutaneous loxoscelism                                                     1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt;   Skin graft detachment                                                     1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt;   Puncture site pain                                                         NA (NA%)            1 (10%)            1 (1.69%)  
#&gt;   Aqueous humour leakage                                                     NA (NA%)            1 (10%)            1 (1.69%)  
#&gt; 
#&gt; Respiratory, thoracic and mediastinal disorders
#&gt;   Total number of events                                                        4                   1                   5      
#&gt;   Total number of patients with at least one adverse event                  4 (8.16%)            1 (10%)            5 (8.47%)  
#&gt;   Respiratory tract oedema                                                  1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt;   Tracheal ulcer                                                            1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt;   Reactive airways dysfunction syndrome                                     1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt;   Portopulmonary hypertension                                                NA (NA%)            1 (10%)            1 (1.69%)  
#&gt;   Young's syndrome                                                          1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt; 
#&gt; Nervous system disorders
#&gt;   Total number of events                                                        2                   2                   4      
#&gt;   Total number of patients with at least one adverse event                  2 (4.08%)            1 (10%)            3 (5.08%)  
#&gt;   Intracranial aneurysm                                                     1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt;   Spinal meningioma malignant                                               1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt;   Cerebral toxoplasmosis                                                     NA (NA%)            1 (10%)            1 (1.69%)  
#&gt;   Glycogen storage disease type III                                          NA (NA%)            1 (10%)            1 (1.69%)  
#&gt; 
#&gt; Skin and subcutaneous tissue disorders
#&gt;   Total number of events                                                        4                   NA                  4      
#&gt;   Total number of patients with at least one adverse event                  3 (6.12%)            NA (NA%)           3 (5.08%)  
#&gt;   Administration site eczema                                                1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt;   Erythema elevatum diutinum                                                1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt;   Eyelid rash                                                               1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt;   Eyelid bleeding                                                           1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt; 
#&gt; Surgical and medical procedures
#&gt;   Total number of events                                                        3                   1                   4      
#&gt;   Total number of patients with at least one adverse event                  2 (4.08%)            1 (10%)            3 (5.08%)  
#&gt;   Fiducial marker placement                                                 1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt;   Therapeutic nerve ablation                                                1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt;   Muscle reattachment                                                       1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt;   Myopia correction                                                          NA (NA%)            1 (10%)            1 (1.69%)  
#&gt; 
#&gt; Gastrointestinal disorders
#&gt;   Total number of events                                                        3                   NA                  3      
#&gt;   Total number of patients with at least one adverse event                  2 (4.08%)            NA (NA%)           2 (3.39%)  
#&gt;   Abdominal wall anomaly                                                    1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt;   Gastroenteritis paracolon bacillus                                        1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt;   Eosinophilic oesophagitis                                                 1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt; 
#&gt; General disorders and administration site conditions
#&gt;   Total number of events                                                        3                   NA                  3      
#&gt;   Total number of patients with at least one adverse event                  3 (6.12%)            NA (NA%)           3 (5.08%)  
#&gt;   Postoperative hernia                                                      1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt;   Pelvic fibrosis                                                           1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt;   Vessel puncture site inflammation                                         1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt; 
#&gt; Musculoskeletal and connective tissue disorders
#&gt;   Total number of events                                                        3                   NA                  3      
#&gt;   Total number of patients with at least one adverse event                  3 (6.12%)            NA (NA%)           3 (5.08%)  
#&gt;   Gout                                                                      1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt;   Serotonin syndrome                                                        1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt;   Myopathy endocrine                                                        1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt; 
#&gt; Vascular disorders
#&gt;   Total number of events                                                        3                   NA                  3      
#&gt;   Total number of patients with at least one adverse event                  2 (4.08%)            NA (NA%)           2 (3.39%)  
#&gt;   Aortic wall hypertrophy                                                   1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt;   Portal fibrosis                                                           1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt;   Stomatitis haemorrhagic                                                   1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt; 
#&gt; Congenital, familial and genetic disorders
#&gt;   Total number of events                                                        2                   NA                  2      
#&gt;   Total number of patients with at least one adverse event                  2 (4.08%)            NA (NA%)           2 (3.39%)  
#&gt;   Congenital hearing disorder                                               1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt;   Extrarenal pelvis                                                         1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt; 
#&gt; Immune system disorders
#&gt;   Total number of events                                                        1                   1                   2      
#&gt;   Total number of patients with at least one adverse event                  1 (2.04%)            1 (10%)            2 (3.39%)  
#&gt;   Tongue oedema                                                             1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt;   Implant site urticaria                                                     NA (NA%)            1 (10%)            1 (1.69%)  
#&gt; 
#&gt; Cardiac disorders
#&gt;   Total number of events                                                        1                   NA                  1      
#&gt;   Total number of patients with at least one adverse event                  1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt;   Corrected transposition of great vessels                                  1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt; 
#&gt; Endocrine disorders
#&gt;   Total number of events                                                        1                   NA                  1      
#&gt;   Total number of patients with at least one adverse event                  1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt;   Growth accelerated                                                        1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt; 
#&gt; Hepatobiliary disorders
#&gt;   Total number of events                                                        1                   NA                  1      
#&gt;   Total number of patients with at least one adverse event                  1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt;   Hepatitis B reactivation                                                  1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt; 
#&gt; Infections and infestations
#&gt;   Total number of events                                                        1                   NA                  1      
#&gt;   Total number of patients with at least one adverse event                  1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt;   Infective pericardial effusion                                            1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt; 
#&gt; Metabolism and nutrition disorders
#&gt;   Total number of events                                                        1                   NA                  1      
#&gt;   Total number of patients with at least one adverse event                  1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt;   Abnormal weight gain                                                      1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt; 
#&gt; Neoplasms benign, malignant and unspecified (incl cysts and polyps)
#&gt;   Total number of events                                                        1                   NA                  1      
#&gt;   Total number of patients with at least one adverse event                  1 (2.04%)            NA (NA%)           1 (1.69%)  
#&gt;   Malignant nipple neoplasm male                                            1 (2.04%)            NA (NA%)           1 (1.69%)  </div><div class='input'>
</div></pre>
  </div>
  <div class="col-md-3 hidden-xs hidden-sm" id="sidebar">
    <h2>Contents</h2>
    <ul class="nav nav-pills nav-stacked">
      <li><a href="#arguments">Arguments</a></li>
            
      <li><a href="#examples">Examples</a></li>
    </ul>

    <h2>Author</h2>
    
Adrian Waddell (waddella) <a href='mailto:adrian.waddell@roche.com'>adrian.waddell@roche.com</a>

Carolyn Zhang (zhanc107) <a href='mailto:carolyn.zhang@duke.edu'>carolyn.zhang@duke.edu</a>

Heng Wang (wangh107) <a href='mailto:wang.heng@gene.com'>wang.heng@gene.com</a>

Ting Qi (qit3) <a href='mailto:qit3@gene.com'>qit3@gene.com</a>

  </div>
</div>

      <footer>
      <div class="copyright">
  <p>Developed by Adrian Waddell, Heng Wang, Yuyao Song, Chendi Liao, Edgar Manukyan, Mark Rothe, Xiao Mu Yo.</p>
</div>

<div class="pkgdown">
  <p>Site built with <a href="http://pkgdown.r-lib.org/">pkgdown</a>.</p>
</div>

      </footer>
   </div>

  

  </body>
</html>

